Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis A: epidemiology and prevention

S M Feinstone1

  • 1Division of Viral Products, Center for Biologics Evaluation and Research, Bethesda, MD 20892, USA.

European Journal of Gastroenterology & Hepatology
|April 1, 1996
PubMed
Summary

Hepatitis A is a global disease influenced by sanitation and individual risk behaviors. While new vaccines offer protection, widespread impact on hepatitis A prevalence requires integration into routine childhood immunization schedules.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neutralizing antibody response during acute and chronic hepatitis C virus infection.

Proceedings of the National Academy of Sciences of the United States of America·2004
Same author

Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein.

Vaccine·2001
Same author

Retraction.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Transfusion-associated hepatitis not due to viral hepatitis type A or B. 1975.

Reviews in medical virology·2001
Same author

Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo.

Journal of virology·2000
Same author

Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.

Proceedings of the National Academy of Sciences of the United States of America·2000

Area of Science:

  • Epidemiology
  • Public Health
  • Vaccinology

Background:

  • Hepatitis A is a globally prevalent infectious disease.
  • Sanitation, hygiene, and individual risk behaviors significantly influence its epidemiology.
  • The recent availability of formalin-inactivated hepatitis A vaccines necessitates strategic implementation.

Purpose of the Study:

  • To understand the epidemiology of Hepatitis A.
  • To inform the optimal use of newly licensed Hepatitis A vaccines in individuals and populations.

Main Methods:

  • Epidemiological analysis of Hepatitis A distribution and transmission factors.
  • Assessment of vaccine efficacy and impact based on epidemiological data.

Main Results:

Related Experiment Videos

  • Higher-risk groups for Hepatitis A can be identified in developed countries.
  • Vaccine use is beneficial for identified high-risk populations.

Conclusions:

  • The widespread impact of Hepatitis A vaccines on overall prevalence is unlikely without inclusion in routine childhood immunization.
  • Targeted vaccination of high-risk groups is a current strategy, but broader public health impact requires broader vaccination programs.